Time to Uveitis Control with Methotrexate and Mycophenolate Mofetil.

Anh D Bui,Christina L Kong,Nicole K Kelly,S R Rathinam,John A Gonzales,Radhika Thundikandy,Anuradha Kanakath,Bala Murugan, R Vedhanayaki,Lyndell L Lim,Eric B Suhler,Hassan A Al-Dhibi,Thuy Doan,Nisha R Acharya

Ophthalmology（2022）

引用 2|浏览9

暂无评分

摘要

This subanalysis from the First-line Antimetabolites as Steroid-sparing Treatment Trial found no significant difference in the time to achieve a corticosteroid-sparing dosage of prednisone for patients with noninfectious uveitis treated with methotrexate versus mycophenolate mofetil.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要